Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients

Bibliographic Details
Main Author: Martins-da-Silva, A
Publication Date: 2014
Other Authors: Lopes, J, Ramalheira, J, Carvalho, C, Cunha, D, Pinho-Costa, P, Silva, B
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.18/2882
Summary: [ENG] Introduction. The determination of human leukocyte antigen (HLA) class II genotype is widely used to confirm the diagnosis of narcolepsy with or without cataplexy. The HLA genotyping is reliable, easy to perform and reassures the clinician. It is also less invasive than other methodologies and is in accordance with the autoimmune hypothesis for the origin of narcolepsy. Aim. To assess the usefulness of genetic markers (HLA) in the differential diagnosis between different sleep disorders and their relevance in the context of our population. Subjects and methods. We analyzed a cohort of 113 patients with episodes of daytime sleepiness, 38 patients were classified as narcolepsy with cataplexy, 13 as narcolepsy and 62 as hypersomnia/idiopathic hypersomnia. A control population of 206 reportedly healthy individuals from the same geographic origin was used. Results. The HLA-DQB1*06:02 allele frequency was overrepresented in patients with narcolepsy and narcolepsy with cataplexy (46% and 71% respectively vs. 16% in control population), with a value of p = 4.53–13 for narcolepsy with cataplexy. The HLA-DQB1*02 frequency was increased in the population with hypersomnia when compared with the control population (55% vs. 34%; p = 0.004). Conclusions. Genetic characterization has the potential to enhance the ability to carry out differential diagnosis among diverse excessive daytime sleepiness phenotypes, corresponding to diverse entities with different biological mechanisms
id RCAP_ecfb837fe0cd21c245f8f6a6196a7c56
oai_identifier_str oai:repositorio.insa.pt:10400.18/2882
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patientsUtilidad de la caracterización genética de la narcolepsia y la hipersomnia en la definición del fenotipo: estudio en pacientes portuguesesHLA-DQB1*06:02HypocretinIdiopathic HypersomniaNarcolepsyNarcolepsy with CataplexySleep DisordersDoenças Genéticas[ENG] Introduction. The determination of human leukocyte antigen (HLA) class II genotype is widely used to confirm the diagnosis of narcolepsy with or without cataplexy. The HLA genotyping is reliable, easy to perform and reassures the clinician. It is also less invasive than other methodologies and is in accordance with the autoimmune hypothesis for the origin of narcolepsy. Aim. To assess the usefulness of genetic markers (HLA) in the differential diagnosis between different sleep disorders and their relevance in the context of our population. Subjects and methods. We analyzed a cohort of 113 patients with episodes of daytime sleepiness, 38 patients were classified as narcolepsy with cataplexy, 13 as narcolepsy and 62 as hypersomnia/idiopathic hypersomnia. A control population of 206 reportedly healthy individuals from the same geographic origin was used. Results. The HLA-DQB1*06:02 allele frequency was overrepresented in patients with narcolepsy and narcolepsy with cataplexy (46% and 71% respectively vs. 16% in control population), with a value of p = 4.53–13 for narcolepsy with cataplexy. The HLA-DQB1*02 frequency was increased in the population with hypersomnia when compared with the control population (55% vs. 34%; p = 0.004). Conclusions. Genetic characterization has the potential to enhance the ability to carry out differential diagnosis among diverse excessive daytime sleepiness phenotypes, corresponding to diverse entities with different biological mechanismsCesar VigueraRepositório Científico do Instituto Nacional de SaúdeMartins-da-Silva, ALopes, JRamalheira, JCarvalho, CCunha, DPinho-Costa, PSilva, B2015-02-17T16:36:45Z2014-01-162014-01-16T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/2882eng10.33588/rn.5802.2013361info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-26T14:08:57Zoai:repositorio.insa.pt:10400.18/2882Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T21:23:35.476708Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
Utilidad de la caracterización genética de la narcolepsia y la hipersomnia en la definición del fenotipo: estudio en pacientes portugueses
title Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
spellingShingle Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
Martins-da-Silva, A
HLA-DQB1*06:02
Hypocretin
Idiopathic Hypersomnia
Narcolepsy
Narcolepsy with Cataplexy
Sleep Disorders
Doenças Genéticas
title_short Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
title_full Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
title_fullStr Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
title_full_unstemmed Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
title_sort Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients
author Martins-da-Silva, A
author_facet Martins-da-Silva, A
Lopes, J
Ramalheira, J
Carvalho, C
Cunha, D
Pinho-Costa, P
Silva, B
author_role author
author2 Lopes, J
Ramalheira, J
Carvalho, C
Cunha, D
Pinho-Costa, P
Silva, B
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Martins-da-Silva, A
Lopes, J
Ramalheira, J
Carvalho, C
Cunha, D
Pinho-Costa, P
Silva, B
dc.subject.por.fl_str_mv HLA-DQB1*06:02
Hypocretin
Idiopathic Hypersomnia
Narcolepsy
Narcolepsy with Cataplexy
Sleep Disorders
Doenças Genéticas
topic HLA-DQB1*06:02
Hypocretin
Idiopathic Hypersomnia
Narcolepsy
Narcolepsy with Cataplexy
Sleep Disorders
Doenças Genéticas
description [ENG] Introduction. The determination of human leukocyte antigen (HLA) class II genotype is widely used to confirm the diagnosis of narcolepsy with or without cataplexy. The HLA genotyping is reliable, easy to perform and reassures the clinician. It is also less invasive than other methodologies and is in accordance with the autoimmune hypothesis for the origin of narcolepsy. Aim. To assess the usefulness of genetic markers (HLA) in the differential diagnosis between different sleep disorders and their relevance in the context of our population. Subjects and methods. We analyzed a cohort of 113 patients with episodes of daytime sleepiness, 38 patients were classified as narcolepsy with cataplexy, 13 as narcolepsy and 62 as hypersomnia/idiopathic hypersomnia. A control population of 206 reportedly healthy individuals from the same geographic origin was used. Results. The HLA-DQB1*06:02 allele frequency was overrepresented in patients with narcolepsy and narcolepsy with cataplexy (46% and 71% respectively vs. 16% in control population), with a value of p = 4.53–13 for narcolepsy with cataplexy. The HLA-DQB1*02 frequency was increased in the population with hypersomnia when compared with the control population (55% vs. 34%; p = 0.004). Conclusions. Genetic characterization has the potential to enhance the ability to carry out differential diagnosis among diverse excessive daytime sleepiness phenotypes, corresponding to diverse entities with different biological mechanisms
publishDate 2014
dc.date.none.fl_str_mv 2014-01-16
2014-01-16T00:00:00Z
2015-02-17T16:36:45Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/2882
url http://hdl.handle.net/10400.18/2882
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.33588/rn.5802.2013361
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cesar Viguera
publisher.none.fl_str_mv Cesar Viguera
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599258254639104